Hussman Strategic Advisors Inc. Raises Stock Position in DaVita Inc. (NYSE:DVA)

Hussman Strategic Advisors Inc. raised its stake in DaVita Inc. (NYSE:DVA - Free Report) by 200.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 25,200 shares of the company's stock after buying an additional 16,800 shares during the quarter. DaVita accounts for about 1.1% of Hussman Strategic Advisors Inc.'s portfolio, making the stock its 10th largest position. Hussman Strategic Advisors Inc.'s holdings in DaVita were worth $3,769,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Transcendent Capital Group LLC acquired a new stake in shares of DaVita in the 3rd quarter valued at approximately $25,000. Blue Trust Inc. grew its holdings in DaVita by 56.4% during the third quarter. Blue Trust Inc. now owns 330 shares of the company's stock valued at $54,000 after purchasing an additional 119 shares during the period. Quarry LP bought a new stake in DaVita in the third quarter valued at approximately $60,000. Venturi Wealth Management LLC raised its holdings in DaVita by 59.8% in the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after purchasing an additional 152 shares during the period. Finally, Versant Capital Management Inc boosted its position in shares of DaVita by 58.7% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $68,000 after purchasing an additional 169 shares in the last quarter. Institutional investors own 90.12% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Barclays upped their price objective on shares of DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat.com, DaVita presently has an average rating of "Hold" and a consensus target price of $162.80.

DaVita Stock Down 2.5 %

DVA stock traded down $3.59 during mid-day trading on Friday, hitting $142.33. 1,605,084 shares of the company were exchanged, compared to its average volume of 845,867. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. DaVita Inc. has a 1-year low of $120.78 and a 1-year high of $179.60. The firm's 50 day simple moving average is $161.03 and its 200 day simple moving average is $157.86. The firm has a market cap of $11.39 billion, a P/E ratio of 13.25, a P/E/G ratio of 1.14 and a beta of 0.94.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings data on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping analysts' consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, sell-side analysts predict that DaVita Inc. will post 10.76 EPS for the current fiscal year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.